News

Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool

NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of…

9 months ago

Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology

Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially…

9 months ago

Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions

ATLANTA , April 07, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive…

9 months ago

ImmuCell Hires Chief Financial Officer

PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…

9 months ago

NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th 

LANGHORNE, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of…

9 months ago

Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025

TAMPA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”),…

9 months ago

Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies

VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the…

9 months ago

Senti Bio Joins Webull Corporate Connect Service Platform

Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for the treatment…

9 months ago

Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity

Dr. Egler brings extensive experience in functional medicine leadership to Noom as it expands its services to meet consumer health…

9 months ago

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in RheumatologyDual CD19/CD70 CAR…

9 months ago